Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 11/20 | 0.60 |
| ▸ | HSD17B2 | P37059 | 11/20 | 0.60 |
| ▸ | APP | P05067 | 5/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | SNCA | P37840 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12562815 | 0.98 | HSD17B1 (0.58) | HSD17B1HSD17B2APPESR2ESR1 | |
| SCHEMBL12562819 | 0.98 | HSD17B1 (0.58) | HSD17B1HSD17B2APPESR2ESR1 | |
| SCHEMBL12562827 | 0.98 | HSD17B1 (0.58) | HSD17B1HSD17B2APPESR2ESR1 | |
| SCHEMBL12562813 | 0.98 | HSD17B1 (0.58) | HSD17B1HSD17B2APPESR2ESR1 | |
| SCHEMBL12562854 | 0.85 | HSD17B1 (0.59) | HSD17B1HSD17B2APPESR2ESR1 | |
| SCHEMBL12562796 | 0.82 | HSD17B1 (0.61) | HSD17B1HSD17B2APPESR2ESR1 | |
| SCHEMBL12562832 | 0.82 | HSD17B1 (0.43) | HSD17B1HSD17B2APPESR2ESR1 | |
| SCHEMBL12562811 | 0.82 | HSD17B1 (0.43) | HSD17B1HSD17B2APPESR2ESR1 | |
| SCHEMBL12562821 | 0.82 | SLC6A4 (0.45) | HSD17B1HSD17B2ESR2ESR1TAAR1 | |
| SCHEMBL12562798 | 0.80 | HSD17B1 (0.59) | HSD17B1HSD17B2APPESR2ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2518075-A1 | INDUCED LAYER MATERIAL FOR PREPARING NON-PLANAR METAL PHTHALOCYANINE WEAK EPITAXY GROWTH THIN FILM | Shanghai Casail Display Technology Ltd. (CN) | 2012-10-31 | — | — | EP | disclosed |
| US-20110152541-A1 | INDUCING LAYER MATERIALS FOR WEAK EPITAXIAL FILMS OF NON-PLANAR METAL PHTHALOCYANINE | SHANGHAI CASAIL DISPLAY TECHNOLOGY LTD. (CN) | 2011-06-23 | — | — | US | disclosed |
| US-20110152541-A1 | INDUCING LAYER MATERIALS FOR WEAK EPITAXIAL FILMS OF NON-PLANAR METAL PHTHALOCYANINE | SHANGHAI CASAIL DISPLAY TECHNOLOGY LTD. (CN) | 2011-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152541-A1 | INDUCING LAYER MATERIALS FOR WEAK EPITAXIAL FILMS OF NON-PLANAR METAL PHTHALOCYANINE | CDYL, PAX3, PAXBP1 | HSD17B1 2793/4885HSD17B2 2870/4885APP 2590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.